Directed-evolution approach to empower EGFR targeting for immunotherapy

Simple item page
dc.contributor.authorMeksiriporn, Bunyarit
dc.contributor.authorSpangler, Jamie B.
dc.date.accessioned2026-08-06T10:45:56Z
dc.date.available2026-08-06T10:45:56Z
dc.date.issued2024-04-22
dc.description.abstractAdvances in directed-evolution technologies are enabling new strategies to isolate binding proteins that recognize disease-associated states of a target protein. In this issue of Cell Reports Methods, Dobersberger et al. devised a yeast display-based selection scheme to discover proteins that engage the cancer-associated activated state of a receptor to enable design of safe and effective immunotherapies.
dc.identifier.citationCell Reports Methods, 4(4), 2024
dc.identifier.doi10.1016/j.crmeth.2024.100762
dc.identifier.issn26672375
dc.identifier.other2-s2.0-85190519808
dc.identifier.urihttps://dspace.kmitl.ac.th/handle/123456789/15600
dc.sourceCell Reports Methods
dc.titleDirected-evolution approach to empower EGFR targeting for immunotherapy
dc.typeNote

Files

Collections

Research